Riskpilot← Back to searchSign inGet full accessPOSEIDON KLINIKKEN AS
ASActiveOrg 994203185Hoffsveien 92, 0377 OsloMedical specialists activities · NACE 8622Est. 20094 employees
Revenue 2020
NOK 6,9M
+16% vs 2019
EBITDA margin
8.6%
+270% vs 2019
Equity ratio
33.9%
Financial strength
Net profit 2020
NOK 431K
+207% vs 2019
| Revenue | NOK 6,9M | +16% |
| EBITDA | NOK 597K | +270% |
| Net profit | NOK 431K | +207% |
| Total assets | NOK 1,6M | +48% |
| Equity | NOK 532K | +427% |
| Employees | 4 | — |
Legal name
POSEIDON KLINIKKEN AS
Org number
994203185
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
13. juni 2009
Share capital
NOK 100 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Fremstilling/salg av hår transplantasjon og andre produkter/tilbud som naturlig faller sammen med dette. Dessuten delta i andre selskaper med samme eller beslektet virksomhet.
Address
Hoffsveien 92, 0377 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 9 322 | 4 619 | 5 504 | 5 982 | 6 911 |
| Staff expenses | −4 018 | −1 642 | −1 627 | −3 529 | −4 362 |
| EBITDA | −678 | −1 368 | −1 458 | −350 | 597 |
| Depreciation & amort. | −69 | −48 | −38 | −47 | −56 |
| EBIT | −748 | −1 416 | −1 497 | −398 | 541 |
| Net financials | 1 | 8 | −6 | −4 | 0 |
| Profit before tax | −747 | −1 408 | −1 503 | −402 | 541 |
| Tax | −0 | −0 | −0 | −0 | 110 |
| Net profit | −747 | −1 408 | −1 503 | −402 | 431 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 1 072 | 2 515 | 2 046 | 1 061 | 1 571 |
| Equity | −2 153 | −159 | −397 | 101 | 532 |
| Long-term debt | 0 | 0 | 0 | 0 | 10 |
| Short-term debt | 3 225 | 2 674 | 2 444 | 960 | 1 029 |
| Total debt | 3 225 | 2 674 | 2 444 | 960 | 1 039 |
EBITDA margin
8.6%
This company
15.8%
Market median
-46% vs market
20162020
Equity ratio
33.9%
This company
38.2%
Market median
+11% vs market
20162020
Return on equity
81.0%
This company
18.4%
Market median
+340% vs market
20162020
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
20162020
Asset turnover
4.40×
This company
1.12×
Market median
+293% vs market
20162020
Debt / equity
1.95×
This company
0.62×
Market median
-215% vs market
20162020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Former (1) | ||
| Board of Directors | 2019 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of POSEIDON KLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martha Mergoudi | Board of Directors | 0 companies |
| Scott Peter Nordsjø Dessingthon | Board of Directors | 0 companies |
| Birger Dessingthon | Chairman | 0 companies |